Stabilized lanthanum carbonate compositions containing a monosaccharide or
disaccharide stabilizing agent are disclosed. Subjects having
hyperphosphatemia can be treated by administering a pharmaceutical
composition containing a therapeutically effective amount of the
stabilized lanthanum carbonate formulation.